← Back to Analyst Consensus 
BIO Hold
BIO-RAD LABORATORIES, INC.
Current Price —
Implied Upside —
Analysts 10
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 4, 2026 (9 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 7, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Aug 5, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| Aug 5, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Aug 5, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| May 1, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Apr 7, 2026 | Citigroup | downgrade | Buy → Neutral | — | 54% |
| Feb 16, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Oct 30, 2025 | Citigroup | maintain | Buy → Buy | $375 | 54% |
| Oct 30, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $340 | 54% |
| Aug 1, 2025 | RBC Capital | maintain | Outperform → Outperform | $409 | 55% |
| Aug 1, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $265 | 54% |
| Jun 9, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $245 | 54% |
| May 2, 2025 | UBS | maintain | Buy → Buy | $310 | 54% |
| May 2, 2025 | Citigroup | maintain | Buy → Buy | $350 | 54% |
| May 2, 2025 | RBC Capital | maintain | Outperform → Outperform | $392 | 55% |
| Apr 17, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $270 | 54% |
| Feb 12, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $345 | 54% |
| Jan 14, 2025 | RBC Capital | reiterate | Outperform → Outperform | $481 | 55% |
| Dec 9, 2024 | RBC Capital | maintain | Outperform → Outperform | $481 | 55% |
| Oct 31, 2024 | Citigroup | maintain | Buy → Buy | $450 | 54% |
| Oct 31, 2024 | RBC Capital | maintain | Outperform → Outperform | $469 | 55% |
| Oct 1, 2024 | Citigroup | upgrade | Neutral → Buy | $400 | 54% |
| Aug 27, 2024 | Wells Fargo | initiate | — → Equal-Weight | $340 | 54% |
| Aug 16, 2024 | RBC Capital | reiterate | Outperform → Outperform | $401 | 55% |
| Aug 2, 2024 | RBC Capital | maintain | Outperform → Outperform | $401 | 55% |
| Aug 2, 2024 | Citigroup | maintain | Neutral → Neutral | $350 | 54% |
| May 8, 2024 | UBS | maintain | Buy → Buy | $385 | 54% |
| Apr 3, 2024 | Citigroup | downgrade | Buy → Neutral | $365 | 54% |
| Feb 16, 2024 | UBS | maintain | Buy → Buy | $420 | 54% |
| Feb 16, 2024 | RBC Capital | maintain | Outperform → Outperform | $480 | 55% |
| Dec 7, 2023 | UBS | initiate | — → Buy | $395 | 54% |
| Aug 7, 2023 | Wells Fargo | maintain | Overweight → Overweight | $525 | 54% |
| Aug 4, 2023 | RBC Capital | maintain | Outperform → Outperform | $524 | 55% |
| Aug 4, 2023 | Credit Suisse | maintain | Outperform → Outperform | $550 | — |
| Jun 16, 2023 | Wells Fargo | initiate | — → Overweight | $550 | 54% |
| May 8, 2023 | Citigroup | maintain | — → Buy | $525 | 54% |
| May 8, 2023 | RBC Capital | maintain | — → Outperform | $531 | 55% |
| May 5, 2023 | Credit Suisse | maintain | — → Outperform | $580 | — |
| Feb 17, 2023 | RBC Capital | maintain | — → Outperform | $579 | 55% |
| Feb 17, 2023 | Credit Suisse | maintain | — → Outperform | $680 | — |
| Dec 7, 2022 | RBC Capital | initiate | — → Outperform | $565 | 55% |
| Oct 28, 2022 | Credit Suisse | maintain | — → Outperform | $640 | — |
| Aug 25, 2022 | Credit Suisse | initiate | — → Outperform | $715 | — |
| Jul 8, 2022 | Citigroup | maintain | — → Buy | $700 | 54% |
| Jul 30, 2021 | Wells Fargo | maintain | — → Overweight | $930 | 54% |
| Feb 12, 2021 | Citigroup | maintain | — → Buy | $750 | 54% |
| Feb 5, 2021 | Jefferies | maintain | — → Buy | $725 | 52% |
| Jul 31, 2020 | Citigroup | maintain | — → Buy | $625 | 54% |
| May 21, 2020 | Wells Fargo | maintain | — → Overweight | $525 | 54% |
| May 7, 2020 | Citigroup | maintain | — → Buy | $525 | 54% |
Price Target Trend
Jun 22, 2026 Latest: $335 Oct 24, 2026
EPS Estimates
0y $9.45
Lo: $8.85 Hi: $10.10
3 analysts ▲4
+1q $3.02
Lo: $2.74 Hi: $3.30
2 analysts ▲1
0q $2.23
Lo: $2.16 Hi: $2.29
2 analysts +1y $9.75
Lo: $8.75 Hi: $10.90
3 analysts ▲4
Cross-Platform Signals
No cross-platform signals in the last 90 days